arrow
R

Renier J. Brentjens

Roswell Park Comprehensive Cancer Center
H指数:77
被引数:3.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies

同种异体现货型CAR T细胞疗法用于复发或难治性B细胞恶性肿瘤

2025-02-051
OA
Developing a membrane-proximal CD33-targeting CAR T cell

开发近膜CD33-targeting CAR T细胞

2024-05-201
OAAI
Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors (Vol 26, pg 453, 2008)
2024-03-260
OA
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results

CD19 CAR T细胞治疗和预防性anakinra治疗复发或难治性淋巴瘤: 2期试验中期结果

2023-07-0363
PRE
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy (March, 10.1038/s41591-022-01702-9, 2022)
2022-10-173
OA
GPRC5D-Targeted CAR T Cells for Myeloma

GPRC5D-Targeted CAR T细胞治疗骨髓瘤

2022-09-29212
OA
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

肠道微生物组与anti-CD19 CAR T细胞治疗后的反应和毒性相关

2022-03-14158
OA